Pfizer Q3 2026 Earnings

Rev: $16.58B (est $15.87B) - Adj EPS: 87c (est 73c) - Sees FY Rev: $62.0B To $64.0B (previously $60.5B To $62.5B) - Sees FY Adj EPS: $2.95 To $3.05 (est $2.96; previously $2.80 To $3)